Oral Antiviral Treatment Available for those who qualify. Find out from our healthcare providers if you qualify for this COVID-19 treatment.
Allow us to cater to your needs for testing and treatment. Whether you test positive for COVID-19 or Influenza (FLU) we maybe able to help you with your treatment.
Every COVID-19 treatment plan is different depending upon the patients unique factors, including, but not limited to, age, your moderate-high risk levels , and your symptoms severity.
The FDA issued Emergency Use Authorization (EUA) for two oral treatments for COVID-19.
Pfizer’s PAXLOVID is for use in COVID-19 positive patients ages 12 and up with a high risk for progression to severe COVID-19. The PAXLOVID prescription includes nirmatrelvir and ritonavir tablets, which must be co-administered.
Merck’s MOLNUPIRAVIR is for use in COVID-19 positive patients ages 18 and up with a high risk for progression to severe COVID-19. This treatment is for alternative use when other treatment is nit available applies when alternative COVID-19 treatment is not accessible or clinically appropriate.
*Treatment is preferred to start as soon as possible or within the first 5 days of symptoms onset.*
For more information, please schedule your telehealth visit online. If you have any questions, please call or email us.
How to receive your COVID-19 treatment plan?
Click link below to register your telehealth visit
Fill out registration information and you will receive a confirmation email link for your confidential meeting via zoom.
Click the Zoom Meeting link under your confirmation email or under your appointment in dashboard a few minutes before you schedule meeting.
Speak to your health care provider
Ability to speak to your healthcare provider online from the convenience of your home.
Choose your preferred pharmacy
Pick up your prescription or get your prescription delivered to you from your preferred pharmacy